By Frank Prenesti
Date: Thursday 16 Jun 2022
LONDON (ShareCast) - (Sharecast News) - Healthcare investment company Syncona reported flat year-end net assets of £1.31bn in its final results on Thursday.
The FTSE 250 firm said that made for net assets per share of 194.4p as at March 31, rising from 193.9p, making for a net asset value total return of 0.3%, down from 4.4% last year.
It said its life science portfolio was valued at £525m, down from £722.1m at year-end, making for a return of 0.8%.
"The business is well positioned to create a diversified portfolio of 15-20 companies with a goal of delivering three to five companies in which we retain a significant ownership interest to the point of product approval on a rolling 10-year basis," Syncona said on Thursday.
"We believe if we achieve this goal, we will deliver transformational outcomes for patients and strong risk-adjusted returns for shareholders."
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 120.80p |
Change Today | -1.20p |
% Change | -0.98 % |
52 Week High | 162.20 |
52 Week Low | 106.20 |
Volume | 229,915 |
Shares Issued | 652.48m |
Market Cap | £788.19m |
Beta | 0.03 |
RiskGrade | 291 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 21-Jun-18 | 20-Jul-17 |
Paid | 30-Jul-18 | 23-Aug-17 |
Amount | 2.30p | 2.30p |
Time | Volume / Share Price |
15:12 | 66 @ 120.80p |
15:05 | 442 @ 120.20p |
15:05 | 58 @ 120.40p |
15:01 | 5 @ 121.00p |
14:49 | 2,756 @ 120.20p |
You are here: research